Catalyst Wire Dossier Catalyst Wire Dossier

Iopofosine I-131 (CLR-131)

Iopofosine I-131 · Cellectar Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Iopofosine I-131 (CLR-131), covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom [Phase 2]

See pricing